Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net
 

Newsletter June 2018

genetherapynetbanner468x60
News: Gene-Therapy Company Crispr Drops as FDA Puts Trial on Hold
Crispr Therapeutics AG plunged after the gene-editing company said a planned trial of its treatment to help people with sickle-cell disease was being put on hold by U.S. regulators. Crispr is developing the therapy with Vertex Pharmaceuticals Inc., and the trial had yet to begin. The companies said in a statement Wednesday that the Food and Drug Administration placed a halt on the experiment until the agency could get more information from the companies.
Read more...

Concerence: 4th Annual Cell & Gene Therapy Congress
Oxford Global is proud to present the 4th Annual Cell & Gene Therapy Congress to be held on the 25-26 of October 2018 in London, UK. Together with our prestigious collocated 7th Annual Cell Culture & Bioprocessing Congress, 5th Annual Stem Cell Congress & Regenerative Medicine Congress and Biobanking Congress, over 400 senior level experts from pharmaceutical and biotechnology companies will meet to discuss the most recent developments and key challenges within the industry.

3 interactive streams:
• Day 1 Stream 1: Cell & Gene Therapy Development & Clinical Trials
• Day 1 Stream 2: Cell & Gene Therapy Bioprocessing & Manufacturing Strategies
• Day 2 Stream 1: Commercialising Cell & Gene Therapy Treatments

Day 1, Stream 1 will concentrate on the development of cell and gene therapy and clinical trials, Including the most recent advances in cell-based therapies, novel vector systems, and the future of cell & gene therapy development. We will have a Stream 2 focusing on bioprocessing and manufacturing strategies for Cell & Gene Therapy. Big challenges such as manufacturing standardisation, product characterisation, and eventual commercialisation will be addressed, as well as ensuring product efficacy, automation and the scaling up/out of manufacturing. Our Day 2 stream explores the commercialisation Cell & Gene Therapy treatments, with regulatory perspectives, challenges pertaining to the development and approval of novel cell and gene therapies, collaboration between industry and academic institutions, and reimbursement and pricing strategies.

Read more...

Conferences
- 15 - 20 June 2018, Monolith Summer School and Symposium (MSS) - Bioprocessing of macromolecules and viruses, Portorož, Slovenia
- 18 - 19 June 2018, International conference on Stem Cells and Regenerative Medicine - Genome editing for targeting genetic diseases, Osaka, Japan
- 27 - 28 June 2018, CAR-TCR Summit Asia, Singapore
- 23 - 24 July 2018, Annual Congress on Advanced Tissue Science and Regenerative Medicine, Rome, Italy
- 26 - 28 July 2018, The 24th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokyo, Japan
- 13 - 17 August 2018, Bioprocessing Summit 2018 - Gene Therapy, Boston, MA
- 4 - 7 September 2018, 4th Annual CAR-TCR Summit 2018, Boston, MA
- 10 - 11 September 2018, International Conference on Cell and Gene Therapy, Dublin, Ireland
- 2 – 3 October 2018, Advanced Therapies Commercialisation Congress, Amsterdam, The Netherlands
- 16 – 19 October 2018, XXVI Congress of the European Society of Gene and Cell Therapy (ESGCT), Lausanne, Swizterland
- 24 – 25 October 2018, Annual Congress on CRISPR-Cas9 Technology, Boston, MA
- 25 – 26 October 2018, 4th Annual Cell & Gene Therapy Congress, London, UK
- 6-8 November 2018, World Orphan Drug Congress 2018, Barcelona, Spain
- 8-9 November 2018, 4th Annual Genome Editing UK Congress, London, UK
- 9-10 November 2018, 2nd Annual Summit on Cell Therapy and Stem Cell Research 2018 Conference, Atlanta, GA
- 23 November 2018, British Society for Gene and Cell Therapy (BSGCT) Annual Conference Autumn 2018, London, UK
- 3 – 5 April 2019, 4th Spring school of the European Society of Gene and Cell Therapy (ESGCT), Naples, Italy
- 29 April - 2 May 2019, American Society of Gene and Cell Therapy (ASGCT) 22th Annual Meeting, Washington, DC
- 21 – 25 October 2019, XXVII Congress of the European Society of Gene and Cell Therapy (ESGCT), Barcelona, Spain

Read more...

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?